230 related articles for article (PubMed ID: 37513746)
21. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
23. Multilocus Sequence Typing of Carbapenem-Resistant
Alam M; Rasool MH; Khan I; Khurshid M; Aslam B
Microb Drug Resist; 2022 Oct; 28(10):997-1002. PubMed ID: 35985003
[No Abstract] [Full Text] [Related]
24. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Hasan B; Perveen K; Olsen B; Zahra R
J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817
[TBL] [Abstract][Full Text] [Related]
25. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
Jo J; Ko KS
Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
[TBL] [Abstract][Full Text] [Related]
26. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
[TBL] [Abstract][Full Text] [Related]
27. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
Akin FE; Bayram A; Balci I
Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
[TBL] [Abstract][Full Text] [Related]
29. Co-existence of
Joshi PR; Acharya M; Kakshapati T; Leungtongkam U; Thummeepak R; Sitthisak S
Antimicrob Resist Infect Control; 2017; 6():21. PubMed ID: 28191309
[TBL] [Abstract][Full Text] [Related]
30. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
[TBL] [Abstract][Full Text] [Related]
31. Spread of the
Chen Y; Gao J; Zhang H; Ying C
Front Microbiol; 2017; 8():163. PubMed ID: 28220115
[TBL] [Abstract][Full Text] [Related]
32. Co-existence of blaOXA-23 and blaVIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital.
Huang ZY; Li J; Shui J; Wang HC; Hu YM; Zou MX
Chin Med J (Engl); 2019 May; 132(10):1166-1172. PubMed ID: 30882466
[TBL] [Abstract][Full Text] [Related]
33. Molecular Detection of
Kaviani R; Pouladi I; Niakan M; Mirnejad R
Rep Biochem Mol Biol; 2020 Jan; 8(4):413-418. PubMed ID: 32582800
[TBL] [Abstract][Full Text] [Related]
34. Dissemination of bla
Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S
Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.
Chen Y; Ai L; Guo P; Huang H; Wu Z; Liang X; Liao K
BMC Infect Dis; 2018 Dec; 18(1):614. PubMed ID: 30509192
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of
Rostami T; Ranjbar M; Ghourchian S; Darzi F; Douraghi M; Nateghi-Rostami M
Health Sci Rep; 2021 Dec; 4(4):e395. PubMed ID: 34622028
[TBL] [Abstract][Full Text] [Related]
38. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
[TBL] [Abstract][Full Text] [Related]
39. Plasmid borne Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) and AdeABC efflux pump conferring carbapenem-tigecycline resistance among Acinetobacter baumannii isolates harboring TnAbaRs.
Savari M; Ekrami A; Shoja S; Bahador A
Microb Pathog; 2017 Mar; 104():310-317. PubMed ID: 28137509
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in
Migliaccio A; Esposito EP; Bagattini M; Berisio R; Triassi M; De Gregorio E; Zarrilli R
Front Microbiol; 2021; 12():790263. PubMed ID: 35197939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
